Checkpoint Capital L.P. has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $182 Billion distributed in 14 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $68.1B, Rhythm Pharmaceuticals, Inc. with a value of $48.1B, Revolution Medicines, Inc. with a value of $13.9B, Soleno Therapeutics Inc with a value of $12.4B, and Disc Medicine Inc with a value of $12.1B.

Examining the 13F form we can see an decrease of $14.2B in the current position value, from $196B to 182B.

Checkpoint Capital L.P. is based out at San Francisco, CA

Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.

Portfolio value $182 Billion
Healthcare: $151 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 14
  • Current Value $182 Billion
  • Prior Value $196 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 5 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Checkpoint Capital L.P. Portfolio

Follow Checkpoint Capital L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checkpoint Capital L.P., based on Form 13F filings with the SEC.

News

Stay updated on Checkpoint Capital L.P. with notifications on news.